Celgene UK and Ireland, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that its phase III clinical trial of ABRAXANE® (nab-paclitaxel) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine in patients with metastatic pancreatic cancer (who… Read More
on 23rd January 2013
Pancreatic Cancer Action (PCA) is to fund researchers at the University of Cambridge to identify the key symptoms associated with pancreatic cancer in order to inform consumer awareness campaigns and underpin the development of general-practice-based interventions aimed at earlier diagnosis… Read More
on 14th January 2013
[caption id="attachment_7412" align="alignright" width="300"] Joanna David, Patron of Pancreatic Cancer Action[/caption] Pancreatic Cancer Action is delighted to announce British actress Joanna David as a new patron. Joanna is one of the UK’s most cherished actresses and has been a familiar… Read More
on 9th January 2013
Caroline describes being diagnosed with having a rare neuroendocrine tumour on her pancreas, and her life after receiving surgery to remove it. Experiencing the symptoms In August 2008 I turned yellow. That was the first sign that something was wrong.… Read More
on 15th February 2011
